These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus. Vesikari T; Vaheri A; Leinikki P Arch Gesamte Virusforsch; 1971; 35(1):25-37. PubMed ID: 4943281 [No Abstract] [Full Text] [Related]
4. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children. Naficy K; Nategh R; Ahangary S; Mohsenin H Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902 [No Abstract] [Full Text] [Related]
5. Avoidance of rubella immunization of women during or shortly before pregnancy. Chin J; Ebbin AJ; Wilson MG; Lennette EH JAMA; 1971 Jan; 215(4):632-4. PubMed ID: 5107445 [No Abstract] [Full Text] [Related]
6. Immunogenicity and reactogenicity of live attenuated rubella virus vaccines. Andzhaparidze OG; Desyatskova RG; Chervonski GI; Pryanichnikova LV Am J Epidemiol; 1970 May; 91(5):527-30. PubMed ID: 5462118 [No Abstract] [Full Text] [Related]
7. A study of rubella immunity and resistance to infection. Davis WJ; Larson HE; Simsarian JP; Parkman PD; Meyer HM JAMA; 1971 Jan; 215(4):600-8. PubMed ID: 5107436 [No Abstract] [Full Text] [Related]
8. Rapid identification of rubella-virus antigen from throat swabs. Haire M Lancet; 1969 May; 1(7601):920-1. PubMed ID: 4180899 [No Abstract] [Full Text] [Related]
9. Experimental active and passive immunization against rubella. Budai J; Tóth M; Melis L Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953 [No Abstract] [Full Text] [Related]
10. An immunologic marker technique for the Cendehill vaccine strain of rubella virus. Oxford JS; Potter CW J Immunol; 1970 Oct; 105(4):818-23. PubMed ID: 5470523 [No Abstract] [Full Text] [Related]
11. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718 [No Abstract] [Full Text] [Related]
13. Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. Horstmann DM; Liebhaber H; Le Bouvier GL; Rosenberg DA; Halstead SB N Engl J Med; 1970 Oct; 283(15):771-8. PubMed ID: 5456233 [No Abstract] [Full Text] [Related]
14. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals. Schluederberg A; Horstmann DM; Andiman WA; Randolph MF J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058 [TBL] [Abstract][Full Text] [Related]
15. Modified hemagglutination-inhibition test for rubella employing human group O erythrocytes. Schmidt NJ; Dennis J Appl Microbiol; 1972 Mar; 23(3):471-5. PubMed ID: 5063201 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of the rubella exanthem. Isolation of rubella virus from the skin. Heggie AD N Engl J Med; 1971 Sep; 285(12):664-6. PubMed ID: 5563480 [No Abstract] [Full Text] [Related]